EPISODE · Feb 15, 2022 · 14 MIN
The FDA on Paxlovid and COVID-19: What physicians need to know, Part II
from AMA Update · host American Medical Association
In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.
Embed this episode
NOW PLAYING
The FDA on Paxlovid and COVID-19: What physicians need to know, Part II
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.